|
Home : Unsafe Drugs : Avandia : Newsfeeds : GlaxoSmithKline sees first-quarter profits rise GlaxoSmithKline sees first-quarter profits rise
The company was hit last year by the EU medicines regulator decision to pull its diabetes product Avandia off the shelves over fears that it increased the risk of heart attack and strokes. Regulators also restricted its availability in the United States.
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




